Published in Neuropsychologia on January 01, 2003
Inverted-U-shaped dopamine actions on human working memory and cognitive control. Biol Psychiatry (2011) 3.78
Differential effects of insular and ventromedial prefrontal cortex lesions on risky decision-making. Brain (2008) 2.82
Shifting and stopping: fronto-striatal substrates, neurochemical modulation and clinical implications. Philos Trans R Soc Lond B Biol Sci (2007) 2.66
Dissociable neural representations of future reward magnitude and delay during temporal discounting. Neuroimage (2008) 2.52
Dopaminergic network differences in human impulsivity. Science (2010) 2.49
Human substantia nigra neurons encode unexpected financial rewards. Science (2009) 2.16
Reward-learning and the novelty-seeking personality: a between- and within-subjects study of the effects of dopamine agonists on young Parkinson's patients. Brain (2009) 2.04
Basal ganglia and dopamine contributions to probabilistic category learning. Neurosci Biobehav Rev (2007) 1.70
Basal ganglia beta oscillations accompany cue utilization. Neuron (2012) 1.63
Impulsive choice and response in dopamine agonist-related impulse control behaviors. Psychopharmacology (Berl) (2009) 1.62
Dopamine enhances model-based over model-free choice behavior. Neuron (2012) 1.53
A thalamocorticostriatal dopamine network for psychostimulant-enhanced human cognitive flexibility. Biol Psychiatry (2012) 1.44
Dopamine, affordance and active inference. PLoS Comput Biol (2012) 1.41
Reward/Punishment reversal learning in older suicide attempters. Am J Psychiatry (2010) 1.36
Parkinson's disease and dopaminergic therapy--differential effects on movement, reward and cognition. Brain (2008) 1.29
The roles of dopamine and serotonin in decision making: evidence from pharmacological experiments in humans. Neuropsychopharmacology (2010) 1.28
Mapping Go-No-Go performance within the subthalamic nucleus region. Brain (2010) 1.26
Decision-making cognition in neurodegenerative diseases. Nat Rev Neurol (2010) 1.20
Risk and learning in impulsive and nonimpulsive patients with Parkinson's disease. Mov Disord (2010) 1.17
Emotion-based decision-making in healthy subjects: short-term effects of reducing dopamine levels. Psychopharmacology (Berl) (2006) 1.16
Striatal Dopamine and the Interface between Motivation and Cognition. Front Psychol (2011) 1.16
Methylphenidate ('Ritalin') can ameliorate abnormal risk-taking behavior in the frontal variant of frontotemporal dementia. Neuropsychopharmacology (2006) 1.14
Differential effects of dopaminergic therapies on dorsal and ventral striatum in Parkinson's disease: implications for cognitive function. Parkinsons Dis (2011) 1.13
Enhanced frontal function in Parkinson's disease. Brain (2009) 1.10
Distinct roles of dopamine and subthalamic nucleus in learning and probabilistic decision making. Brain (2012) 1.07
Extrastriatal dopaminergic abnormalities of DA homeostasis in Parkinson's patients with medication-induced pathological gambling: a [11C] FLB-457 and PET study. Neurobiol Dis (2012) 1.05
Decision making, impulsivity, and addictions: do Parkinson's disease patients jump to conclusions? Mov Disord (2012) 1.03
Human cognitive flexibility depends on dopamine D2 receptor signaling. Psychopharmacology (Berl) (2011) 1.03
Differential influence of levodopa on reward-based learning in Parkinson's disease. Front Hum Neurosci (2010) 1.01
Dopaminergic Modulation of Decision Making and Subjective Well-Being. J Neurosci (2015) 1.01
Cognitive impairment in Parkinson's disease: the dual syndrome hypothesis. Neurodegener Dis (2012) 1.00
Deficits in inhibitory control and conflict resolution on cognitive and motor tasks in Parkinson's disease. Exp Brain Res (2011) 1.00
The dopamine D2 receptor antagonist sulpiride modulates striatal BOLD signal during the manipulation of information in working memory. Psychopharmacology (Berl) (2009) 1.00
Saccadic latency distributions in Parkinson's disease and the effects of L-dopa. Exp Brain Res (2006) 0.98
Stroop test performance in impulsive and non impulsive patients with Parkinson's disease. Parkinsonism Relat Disord (2011) 0.97
Effect of levodopa on cognitive function in Parkinson's disease with and without dementia and dementia with Lewy bodies. J Neurol Neurosurg Psychiatry (2006) 0.95
Resting state networks distinguish human ventral tegmental area from substantia nigra. Neuroimage (2014) 0.94
Dissociable frontal-striatal and frontal-parietal networks involved in updating hierarchical contexts in working memory. Cereb Cortex (2012) 0.93
Acute and chronic cognitive effects of levodopa and dopamine agonists on patients with Parkinson's disease: a review. Ther Adv Psychopharmacol (2013) 0.92
A pattern of perseveration in cocaine addiction may reveal neurocognitive processes implicit in the Wisconsin Card Sorting Test. Neuropsychologia (2011) 0.91
Improving response inhibition in Parkinson's disease with atomoxetine. Biol Psychiatry (2014) 0.91
Optogenetics enlightens neuroscience drug discovery. Nat Rev Drug Discov (2015) 0.90
The effect of dopamine agonists on adaptive and aberrant salience in Parkinson's disease. Neuropsychopharmacology (2011) 0.89
Dopamine treatment and cognitive functioning in individuals with Parkinson's disease: the "cognitive flexibility" hypothesis seems to work. Behav Neurol (2014) 0.88
L-DOPA-induced dysregulation of extrastriatal dopamine and serotonin and affective symptoms in a bilateral rat model of Parkinson's disease. Neuroscience (2012) 0.88
Multiple modes of impulsivity in Parkinson's disease. PLoS One (2014) 0.87
A neurocomputational model of tonic and phasic dopamine in action selection: a comparison with cognitive deficits in Parkinson's disease. Behav Brain Res (2009) 0.87
The ethics of elective psychopharmacology. Int J Neuropsychopharmacol (2011) 0.85
Depression of Serotonin Synaptic Transmission by the Dopamine Precursor L-DOPA. Cell Rep (2015) 0.84
Attentional set-shifting deficit in Parkinson's disease is associated with prefrontal dysfunction: an FDG-PET study. PLoS One (2012) 0.83
Increased reflection impulsivity in patients with ephedrone-induced Parkinsonism. Addiction (2013) 0.83
Decision making and executive functions in REM sleep behavior disorder. Sleep (2012) 0.83
Perseveration and choice in Parkinson's disease: the impact of progressive frontostriatal dysfunction on action decisions. Cereb Cortex (2012) 0.82
Preliminary evaluation of the DDS-PC inventory: a new tool to assess impulsive-compulsive behaviours associated to dopamine replacement therapy in Parkinson's disease. Neurol Sci (2009) 0.81
Detecting associations between behavioral addictions and dopamine agonists in the Food & Drug Administration's Adverse Event database. J Behav Addict (2014) 0.81
Dopaminergic function and intertemporal choice. Transl Psychiatry (2015) 0.81
Rule-based categorization deficits in focal basal ganglia lesion and Parkinson's disease patients. Neuropsychologia (2010) 0.81
Imaging of Dopamine in PD and Implications for Motor and Neuropsychiatric Manifestations of PD. Front Neurol (2013) 0.81
Dopamine Increases a Value-Independent Gambling Propensity. Neuropsychopharmacology (2016) 0.80
Computational model of precision grip in Parkinson's disease: a utility based approach. Front Comput Neurosci (2013) 0.80
Decision and dopaminergic system: an ERPs study of Iowa gambling task in Parkinson's disease. Front Psychol (2014) 0.80
Dopaminergic medication impairs feedback-based stimulus-response learning but not response selection in Parkinson's disease. Front Hum Neurosci (2014) 0.80
Emotion recognition in early Parkinson's disease patients undergoing deep brain stimulation or dopaminergic therapy: a comparison to healthy participants. Front Aging Neurosci (2015) 0.80
Dopamine enhances willingness to exert effort for reward in Parkinson's disease. Cortex (2015) 0.80
Biological changes associated with healthy versus pathological aging: a symposium review. Ageing Res Rev (2009) 0.80
COMT and ANKK1 Genetics Interact With Depression to Influence Behavior Following Severe TBI: An Initial Assessment. Neurorehabil Neural Repair (2016) 0.79
Neuroimaging studies of striatum in cognition part II: Parkinson's disease. Front Syst Neurosci (2015) 0.79
The Effect of Dopaminergic Medication on Beat-Based Auditory Timing in Parkinson's Disease. Front Neurol (2016) 0.79
Assaying the effect of levodopa on the evaluation of risk in healthy humans. PLoS One (2013) 0.79
Frontostriatal cognitive staging in Parkinson's disease. Parkinsons Dis (2011) 0.79
Decision making in juvenile myoclonic epilepsy. J Neurol (2012) 0.78
Individual differences in impulsivity predict anticipatory eye movements. PLoS One (2011) 0.78
Limited Effect of Dopaminergic Medication on Straight Walking and Turning in Early-to-Moderate Parkinson's Disease during Single and Dual Tasking. Front Aging Neurosci (2016) 0.78
Impulsivities and Parkinson's disease: delay aversion is not worsened by Deep Brain Stimulation of the subthalamic nucleus. PLoS One (2012) 0.78
Amelioration of non-motor dysfunctions after transplantation of human dopamine neurons in a model of Parkinson's disease. Exp Neurol (2016) 0.78
The neurobiology and neural circuitry of cognitive changes in Parkinson's disease revealed by functional neuroimaging. Mov Disord (2012) 0.78
Dopaminergic modulation of memory and affective processing in Parkinson depression. Psychiatry Res (2013) 0.78
Betting on DBS: Effects of subthalamic nucleus deep brain stimulation on risk taking and decision making in patients with Parkinson's disease. Neuropsychology (2014) 0.78
Combined D1/D2 receptor stimulation under conditions of dopamine depletion impairs spatial working memory performance in humans. Psychopharmacology (Berl) (2005) 0.78
Levodopa impairs probabilistic reversal learning in healthy young adults. Psychopharmacology (Berl) (2016) 0.78
Delay and probability discounting as candidate markers for dementia: an initial investigation. Arch Clin Neuropsychol (2014) 0.78
Reward sensitivity deficits modulated by dopamine are associated with apathy in Parkinson's disease. Brain (2016) 0.78
Mental Side Effects of Deep Brain Stimulation (DBS) for Movement Disorders: The Futility of Denial. Front Integr Neurosci (2016) 0.77
Paradoxical effect of dopamine medication on cognition in Parkinson's disease: relationship to side of motor onset. J Int Neuropsychol Soc (2015) 0.77
The Effects of Acute Dopamine Precursor Depletion on the Cognitive Control Functions of Performance Monitoring and Conflict Processing: An Event-Related Potential (ERP) Study. PLoS One (2015) 0.77
Dopamine Selectively Modulates the Outcome of Learning Unnatural Action-Valence Associations. J Cogn Neurosci (2017) 0.76
Dopa therapy and action impulsivity: subthreshold error activation and suppression in Parkinson's disease. Psychopharmacology (Berl) (2014) 0.76
Dopamine, Salience, and Response Set Shifting in Prefrontal Cortex. Cereb Cortex (2014) 0.76
Neural and behavioral substrates of subtypes of Parkinson's disease. Front Syst Neurosci (2013) 0.76
Multi-facetted impulsivity following nigral degeneration and dopamine replacement therapy. Neuropharmacology (2016) 0.76
Deep Brain Stimulation of the Subthalamic Nucleus Improves Lexical Switching in Parkinsons Disease Patients. PLoS One (2016) 0.76
Pramipexole Impairs Stimulus-Response Learning in Healthy Young Adults. Front Neurosci (2016) 0.75
Time on timing: Dissociating premature responding from interval sensitivity in Parkinson's disease. Mov Disord (2016) 0.75
Differential effects of dopamine-directed treatments on cognition. Neuropsychiatr Dis Treat (2015) 0.75
Impaired Switching from Self-Prepared Actions in Mild Parkinson Disease. J Parkinsons Dis (2015) 0.75
Sentence comprehension and its association with executive functions in patients with Parkinson's disease. Parkinsons Dis (2011) 0.75
Pramipexole Increases Go Timeouts but Not No-go Errors in Healthy Volunteers. Front Hum Neurosci (2016) 0.75
Dopamine D1/D2 Receptor Activity in the Nucleus Accumbens Core But Not in the Nucleus Accumbens Shell and Orbitofrontal Cortex Modulates Risk-Based Decision Making. Int J Neuropsychopharmacol (2015) 0.75
Dopaminergic Medication Modulates Learning from Feedback and Error-Related Negativity in Parkinson's Disease: A Pilot Study. Front Behav Neurosci (2016) 0.75
Dopamine and temporal attention: An attentional blink study in Parkinson's disease patients on and off medication. Neuropsychologia (2016) 0.75
Neural systems of reinforcement for drug addiction: from actions to habits to compulsion. Nat Neurosci (2005) 16.18
Inhibition and the right inferior frontal cortex. Trends Cogn Sci (2004) 9.78
Grand challenges in global mental health. Nature (2011) 8.40
Nucleus accumbens D2/3 receptors predict trait impulsivity and cocaine reinforcement. Science (2007) 6.75
Stop-signal inhibition disrupted by damage to right inferior frontal gyrus in humans. Nat Neurosci (2003) 5.94
Putting a spin on the dorsal-ventral divide of the striatum. Trends Neurosci (2004) 5.55
Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines. Mov Disord (2012) 5.12
Review. Neural mechanisms underlying the vulnerability to develop compulsive drug-seeking habits and addiction. Philos Trans R Soc Lond B Biol Sci (2008) 4.85
High impulsivity predicts the switch to compulsive cocaine-taking. Science (2008) 4.76
Prefrontal executive and cognitive functions in rodents: neural and neurochemical substrates. Neurosci Biobehav Rev (2004) 4.38
Cognition in schizophrenia: summary Nice Consultation Meeting 2012. Eur Neuropsychopharmacol (2013) 3.99
Impulsivity, compulsivity, and top-down cognitive control. Neuron (2011) 3.96
The mental wealth of nations. Nature (2008) 3.60
Integrating evidence from neuroimaging and neuropsychological studies of obsessive-compulsive disorder: the orbitofronto-striatal model revisited. Neurosci Biobehav Rev (2007) 3.51
Defining the neural mechanisms of probabilistic reversal learning using event-related functional magnetic resonance imaging. J Neurosci (2002) 3.50
Contrasting roles of basolateral amygdala and orbitofrontal cortex in impulsive choice. J Neurosci (2004) 3.48
Dissection of the genetics of Parkinson's disease identifies an additional association 5' of SNCA and multiple associated haplotypes at 17q21. Hum Mol Genet (2010) 3.34
The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort. Brain (2009) 3.03
Behavioral models of impulsivity in relation to ADHD: translation between clinical and preclinical studies. Clin Psychol Rev (2006) 2.96
Serotoninergic regulation of emotional and behavioural control processes. Trends Cogn Sci (2007) 2.95
Abnormal brain structure implicated in stimulant drug addiction. Science (2012) 2.85
Inhibition and impulsivity: behavioral and neural basis of response control. Prog Neurobiol (2013) 2.85
The cognitive ability of an incident cohort of Parkinson's patients in the UK. The CamPaIGN study. Brain (2003) 2.81
Appetitive behavior: impact of amygdala-dependent mechanisms of emotional learning. Ann N Y Acad Sci (2003) 2.70
Parallel and interactive learning processes within the basal ganglia: relevance for the understanding of addiction. Behav Brain Res (2008) 2.61
Probing compulsive and impulsive behaviors, from animal models to endophenotypes: a narrative review. Neuropsychopharmacology (2009) 2.60
Differential control over cocaine-seeking behavior by nucleus accumbens core and shell. Nat Neurosci (2004) 2.52
Serotonin modulates behavioral reactions to unfairness. Science (2008) 2.49
Dopamine release in the dorsal striatum during cocaine-seeking behavior under the control of a drug-associated cue. J Neurosci (2002) 2.49
Serotonin selectively influences moral judgment and behavior through effects on harm aversion. Proc Natl Acad Sci U S A (2010) 2.47
Neurochemical modulation of response inhibition and probabilistic learning in humans. Science (2006) 2.41
The neural basis of mood-congruent processing biases in depression. Arch Gen Psychiatry (2002) 2.35
Disintegration of the sleep-wake cycle and circadian timing in Huntington's disease. J Neurosci (2005) 2.34
Limbic corticostriatal systems and delayed reinforcement. Ann N Y Acad Sci (2004) 2.24
Disruption in the balance between goal-directed behavior and habit learning in obsessive-compulsive disorder. Am J Psychiatry (2011) 2.24
Cognitive impairments in early Parkinson's disease are accompanied by reductions in activity in frontostriatal neural circuitry. J Neurosci (2003) 2.22
Serotonergic and dopaminergic modulation of gambling behavior as assessed using a novel rat gambling task. Neuropsychopharmacology (2009) 2.21
Orbitofrontal dysfunction in patients with obsessive-compulsive disorder and their unaffected relatives. Science (2008) 2.20
The CamPaIGN study of Parkinson's disease: 10-year outlook in an incident population-based cohort. J Neurol Neurosurg Psychiatry (2013) 2.20
Neurobehavioral mechanisms of impulsivity: fronto-striatal systems and functional neurochemistry. Pharmacol Biochem Behav (2007) 2.19
The application of the 5-choice serial reaction time task for the assessment of visual attentional processes and impulse control in rats. Nat Protoc (2008) 2.17
Cognitive enhancing effects of modafinil in healthy volunteers. Psychopharmacology (Berl) (2002) 2.17
Drug addiction endophenotypes: impulsive versus sensation-seeking personality traits. Biol Psychiatry (2010) 2.13
Risk taking during decision-making in normal volunteers changes with age. J Int Neuropsychol Soc (2004) 2.12
A componential analysis of task-switching deficits associated with lesions of left and right frontal cortex. Brain (2004) 2.11
A novel neuroprotective therapy for Parkinson's disease using a viral noncoding RNA that protects mitochondrial complex I activity. J Exp Med (2011) 2.10
Reflection impulsivity in current and former substance users. Biol Psychiatry (2006) 2.09
The natural history of treated Parkinson's disease in an incident, community based cohort. J Neurol Neurosurg Psychiatry (2011) 2.08
The neuropsychopharmacology of action inhibition: cross-species translation of the stop-signal and go/no-go tasks. Psychopharmacology (Berl) (2008) 2.07
Cognitive dysfunction and anxious-impulsive personality traits are endophenotypes for drug dependence. Am J Psychiatry (2012) 2.05
Decision-making in the adolescent brain. Nat Neurosci (2012) 2.05
Reconciling the role of serotonin in behavioral inhibition and aversion: acute tryptophan depletion abolishes punishment-induced inhibition in humans. J Neurosci (2009) 2.04
Fractionating impulsivity: contrasting effects of central 5-HT depletion on different measures of impulsive behavior. Neuropsychopharmacology (2004) 2.03
Abnormal structure of frontostriatal brain systems is associated with aspects of impulsivity and compulsivity in cocaine dependence. Brain (2011) 2.00
Tryptophan depletion alters the decision-making of healthy volunteers through altered processing of reward cues. Neuropsychopharmacology (2003) 1.99
Health-related quality of life in early Parkinson's disease: the impact of nonmotor symptoms. Mov Disord (2013) 1.98
Adolescent impulsivity phenotypes characterized by distinct brain networks. Nat Neurosci (2012) 1.98
Stop-signal reaction-time task performance: role of prefrontal cortex and subthalamic nucleus. Cereb Cortex (2007) 1.95
Tau and alpha-synuclein in susceptibility to, and dementia in, Parkinson's disease. Ann Neurol (2007) 1.95
Time-limited modulation of appetitive Pavlovian memory by D1 and NMDA receptors in the nucleus accumbens. Proc Natl Acad Sci U S A (2005) 1.94
Microglial activation in presymptomatic Huntington's disease gene carriers. Brain (2007) 1.93
Neurocognitive mechanisms in depression: implications for treatment. Annu Rev Neurosci (2009) 1.92
Motor inhibition and cognitive flexibility in obsessive-compulsive disorder and trichotillomania. Am J Psychiatry (2006) 1.92
The neuropsychiatry of impulsivity. Curr Opin Psychiatry (2007) 1.90
Methylphenidate improves response inhibition in adults with attention-deficit/hyperactivity disorder. Biol Psychiatry (2003) 1.89
Atomoxetine modulates right inferior frontal activation during inhibitory control: a pharmacological functional magnetic resonance imaging study. Biol Psychiatry (2008) 1.89
Interactions between serotonin and dopamine in the control of impulsive choice in rats: therapeutic implications for impulse control disorders. Neuropsychopharmacology (2005) 1.89
From the ventral to the dorsal striatum: devolving views of their roles in drug addiction. Neurosci Biobehav Rev (2013) 1.88
Lesions of the medial striatum in monkeys produce perseverative impairments during reversal learning similar to those produced by lesions of the orbitofrontal cortex. J Neurosci (2008) 1.88
Learning and cognitive flexibility: frontostriatal function and monoaminergic modulation. Curr Opin Neurobiol (2010) 1.85
Atomoxetine improved response inhibition in adults with attention deficit/hyperactivity disorder. Biol Psychiatry (2007) 1.82
Neurocognitive endophenotypes of obsessive-compulsive disorder. Brain (2007) 1.81
Profile of executive and memory function associated with amphetamine and opiate dependence. Neuropsychopharmacology (2006) 1.81
Lifting the veil on trichotillomania. Am J Psychiatry (2007) 1.81
Similar effects of the selective noradrenaline reuptake inhibitor atomoxetine on three distinct forms of impulsivity in the rat. Neuropsychopharmacology (2007) 1.81
The roles of dopamine and noradrenaline in the pathophysiology and treatment of attention-deficit/hyperactivity disorder. Biol Psychiatry (2011) 1.80
Double dissociation between serotonergic and dopaminergic modulation of medial prefrontal and orbitofrontal cortex during a test of impulsive choice. Cereb Cortex (2005) 1.80
Chronic cocaine but not chronic amphetamine use is associated with perseverative responding in humans. Psychopharmacology (Berl) (2008) 1.79